• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation

Immunoregulation in Inflammatory Bowel Diseases - Current Understanding and Innovation

Hardcover

Series: Falk Symposium, Book 153

Medical Reference

ISBN10: 1402058888
ISBN13: 9781402058882
Publisher: Springer Nature
Published: Feb 28 2007
Pages: 216
Weight: 1.00
Height: 0.80 Width: 6.20 Depth: 9.20
Language: English

Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand, new therapeutic options have emerged. These include modern immunomodulators, biologics, probiotics, worm eggs and extracorporeal therapies. The clinical relevance of these new modalities is often difficult to assess for physicians who do not work frequently with IBD patients.

Also in

Medical Reference